Endocarditis infecciosa, una entidad que precisa de los niveles asistenciales geriátricos / Endocarditis; an entity that requires geriatric care models

No disponible

Pancitopenia en el curso de infección por SARS-CoV-2 / Pancytopenia during SARS-CoV-2 infection

No disponible

Parkinsonismo inducido por fármacos / Drug-induced Parkinsonism

No disponible

Neuromyelitis optica and tactile and visual hallucinations in an elderly patient.

Although neuromyelitis optica initially described by Eugen Devic in 1897 was considered for many years as a variant of multiple sclerosis, clinical course, more aggressive from the start, progressive towards severe disability and poor visual prognosis, and a different response to treatment, clearly point to a different process. Anti-aquaporin 4 antibodies are a specific biomarker of the entity and, since their discovery, both the number of symptoms and the radiological data about the disease have progressively increased, and the concept of clinical spectrum of neuromyelitis optica has been defined. To our knowledge it is the first reported case of encephalopathy and neuromyelitis optica in elderly patient.

Influencia de la duración de la estancia hospitalaria sobre la mortalidad tras el alta en pacientes mayores con patología médica aguda / Influence of length of hospital stay on mortality after discharge in older patients with acute medical diseases

Objetivo: Analizar la influencia de la estancia hospitalaria sobre la mortalidad a los 6 meses del alta en ancianos. Métodos: Estudio longitudinal observacional en pacientes supervivientes al alta tras un ingreso hospitalario. Se realizó un análisis de regresión logística binaria para estudiar factores relacionados con la estancia prolongada (>12 días). Se estudió la relación entre la mortalidad a los 6 meses y los cuartiles de estancia mediante un análisis de regresión de Cox. Resultados: Se estudiaron 1180 pacientes, con una edad media de 86,6 años (desviación estándar: 6,9). La mediana de estancia fue de 8 días (rango intercuartílico: 5-12). La mortalidad a los 6 meses fue del 26,1%. Tras ajustar por edad, sexo, diagnóstico principal, comorbilidad, albúmina al ingreso, deterioro funcional al ingreso y situación funcional y mental al alta, la estancia por encima de la mediana se relacionó con la mortalidad a los 6 meses: para 9-12 días, hazard ratio (HR) de 1,79 e intervalo de confianza del 95% (IC95%) de 1,01-3,14; para más de 12 días, HR de 2,04 e IC95% de 1,19-3,53. Conclusiones: La estancia hospitalaria prolongada es un factor de riesgo independiente de mortalidad a los 6 meses tras la hospitalización (AU)

Objective: To analyse whether hospital length of stay is associated with mortality at six months after discharge in the elderly. Methods: An observational longitudinal study of patients surviving at hospital discharge. A binary logistic regression analysis was performed to study factors related to extended stay (> 12 days). The relationship between mortality at 6 months and length-of-stay quartiles was studied using a Cox regression analysis. Results: 1180 patients were studied with a mean age of 86.6 years (standard deviation: 6.9). The median length of stay was 8 days (interquartile range: 5-12). Six-month mortality was 26.1%. After adjusting for age, gender, main diagnosis, comorbidity, albumin at admission, functional deterioration at admission and functional and mental status at discharge, hospital stay above the median was associated with mortality at 6 months: 9-12 days, HR=1.79, 95% CI: 1.01-3.14; and > 12 days, HR=2.04, 95% CI: 1.19-3.53. Conclusions Prolonged hospital stay is an independent risk factor for mortality at 6 months after discharge (AU)

Síndrome neuroléptico maligno asociado a quetiapina tras retirada de olanzapina y donepezilo, con EEG con diagnóstico diferencial para enfermedad de Creutzfeldt-Jakob / Neuroleptic malignant syndrome associated with quetiapine after withdrawal of olanzapine and donepezil, with EEG differential diagnosis of Creutzfeldt-Jakob disease

No disponible

[Influence of length of hospital stay on mortality after discharge in older patients with acute medical diseases]. / Influencia de la duración de la estancia hospitalaria sobre la mortalidad tras el alta en pacientes mayores con patología médica aguda.

OBJECTIVE: To analyse whether hospital length of stay is associated with mortality at six months after discharge in the elderly. METHODS: An observational longitudinal study of patients surviving at hospital discharge. A binary logistic regression analysis was performed to study factors related to extended stay (> 12 days). The relationship between mortality at 6 months and length-of-stay quartiles was studied using a Cox regression analysis. RESULTS: 1180 patients were studied with a mean age of 86.6 years (standard deviation: 6.9). The median length of stay was 8 days (interquartile range: 5-12). Six-month mortality was 26.1%. After adjusting for age, gender, main diagnosis, comorbidity, albumin at admission, functional deterioration at admission and functional and mental status at discharge, hospital stay above the median was associated with mortality at 6 months: 9-12 days, HR=1.79, 95% CI: 1.01-3.14; and > 12 days, HR=2.04, 95% CI: 1.19-3.53. CONCLUSIONS: Prolonged hospital stay is an independent risk factor for mortality at 6 months after discharge.

Mioclonías por fentanilo. A propósito de un caso / Myoclonus due to fentanyl. Report of a case

No disponible